REGALINS
Investo's verdict, shared with you
No fair value published
The derivation ran and was refused by our own plausibility checks — so we publish no number rather than a plausible-looking one.
Why
Our valuation methods disagree
The earnings-based and book-based readings of this company differ by more than 2.5×. That spread is real information, but averaging it would manufacture a number no method actually produced.
What we would need
- Earnings and book value drawn from the same set of accounts, so the two legs can be reconciled.
Show what the engine computed
Method spread · 3.41× between the highest and lowest valuation leg.
Methods disagree · The valuation legs disagree by 3.41x (Blended P/E band ₦0.29 vs Blended P/B band ₦0.99 vs Justified P/B ₦0.38). No point estimate is defensible until the inputs are reconciled.
Regal Insurance Plc trades at ₦0.82, implying a P/E of ~21x on annualised EPS of ₦0.04 — a significant premium to the sector median of 7.42x — while delivering a structurally weak ROE of ~4% against an estimated cost of equity of ~18%, destroying book value economically. The committee score scores negative on Value, Quality, and Momentum, with no dividend yield and only one clean annual reporting year, leaving the investment case bereft of a durable earnings anchor. Until recapitalisation proceeds translate into measurable improvement in underwriting profitability and ROE, the risk/reward at the current price is unattractive.
Verdict published 2026-08-18 · fundamentals through 2nd quarter 2026 · reviewed as the data changes
Verdict moderated to Watch — Avoid was refused
The valuation legs disagree by 3.41x, so there is no defensible valuation behind an extreme call.
Source: NGX live market data · Investo intelligence. Educational only — not financial advice.